ANNA Becomes Pioneer Member of Kidney Health Initiative

ANNA recently became a “pioneer member” of the Kidney Health Initiative (KHI), a collaborative group of stakeholders in the kidney community seeking to help foster optimum therapies for diseases that affect the kidney. KHI’s mission is to “advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and foster development of therapies for disease that affect the kidney by creating a collaborative environment in which the Food and Drug Administration (FDA) and the greater nephrology community can interact to optimize the evaluation of drugs, devices, biologics, and food products.”